BMP2 and chronic kidney disease: In summary, hyperphosphatemia can be seen as the initiating factor in a series of regulatory mechanisms during the VC process secondary to CKD, mediating the expression of BMP2 and RUNX2, which are crucial molecules affecting the VC process.